SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3.29 |
| Enterprise Value ($M) | 4.34 |
| Book Value ($M) | -2.14 |
| Book Value / Share | -2.91 |
| Price / Book | -1.54 |
| NCAV ($M) | -2.14 |
| NCAV / Share | -2.91 |
| Price / NCAV | -1.54 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -1.82 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.52 |
| Current Ratio | 0.52 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2.31 |
| Assets | 2.31 |
| Liabilities | 4.45 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 8,973 | 27,762 | 32.32 | |
| 17,848 | 56,486 | 31.60 | |
| 34,421 | 84,807 | 40.59 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PTIX – Protagenic Therapeutics, Inc. | PTPI – Petros Pharmaceuticals, Inc. |
| PULM – Pulmatrix, Inc. | RENB – Renovaro Inc. |
| REVB – Revelation Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io